The Board has decided to remand the Veteran's claim for an initial compensable rating for dyshidrotic eczema, bilateral feet due to insufficient medical opinions regarding whether topical corticosteroid treatment is systemic therapy.
The deciding factor: Insufficient medical opinions were provided regarding whether Clobetasol treatment is systemic therapy or if other immunosuppressive drugs are systemic therapy.
- Claimed conditions
- dyshidrotic eczema
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- April 5, 2019
- Citation
- 19125940
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied a compensable disability rating for dyshidrotic eczema as the evidence did not support a higher rating under applicable criteria.
- Dismissed
All claims for service connection and increased disability ratings have been withdrawn by the appellant, thus they are dismissed.
- Denied
The Board denied a compensable disability rating for the Veteran's dyshidrotic eczema as it does not meet the criteria for a compensable rating under the applicable regulations.
- Denied
The Board denied the Veteran's claims for service connection for an acquired psychiatric disorder and a compensable disability rating for dyshidrotic eczema.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.